Rationale and Design of the B-PROOF Study, a Randomized Controlled Trial on the Effect of Supplemental Intake of Vitamin B12 and Folic Acid on Fracture Incidence

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2011 Dec 6

PMID 22136481

Citations 47

Authors

Janneke P van Wijngaarden

Rosalie A M Dhonukshe-Rutten

Natasja M van Schoor

Nathalie Van der Velde

Karin M A Swart

Anke W Enneman

Suzanne C van Dijk

Elske M Brouwer-Brolsma

M Carola Zillikens

Joyce B J van Meurs

Johannes Brug

Andre G Uitterlinden

Paul Lips

Lisette C P G M de Groot

Affiliations

Soon will be listed here.

Abstract

Background: Osteoporosis is a major health problem, and the economic burden is expected to rise due to an increase in life expectancy throughout the world. Current observational evidence suggests that an elevated homocysteine concentration and poor vitamin B12 and folate status are associated with an increased fracture risk. As vitamin B12 and folate intake and status play a large role in homocysteine metabolism, it is hypothesized that supplementation with these B-vitamins will reduce fracture incidence in elderly people with an elevated homocysteine concentration.

Methods/design: The B-PROOF (B-Vitamins for the PRevention Of Osteoporotic Fractures) study is a randomized double-blind placebo-controlled trial. The intervention comprises a period of two years, and includes 2919 subjects, aged 65 years and older, independently living or institutionalized, with an elevated homocysteine concentration (≥ 12 μmol/L). One group receives daily a tablet with 500 μg vitamin B12 and 400 μg folic acid and the other group receives a placebo tablet. In both tablets 15 μg (600 IU) vitamin D is included. The primary outcome of the study is osteoporotic fractures. Measurements are performed at baseline and after two years and cover bone health i.e. bone mineral density and bone turnover markers, physical performance and physical activity including falls, nutritional intake and status, cognitive function, depression, genetics and quality of life. This large multi-center project is carried out by a consortium from the Erasmus MC (Rotterdam, the Netherlands), VUmc (Amsterdam, the Netherlands) and Wageningen University, (Wageningen, the Netherlands), the latter acting as coordinator.

Discussion: To our best knowledge, the B-PROOF study is the first intervention study in which the effect of vitamin B12 and folic acid supplementation on osteoporotic fractures is studied in a general elderly population. We expect the first longitudinal results of the B-PROOF intervention in the second semester of 2013. The results of this intervention will provide evidence on the efficacy of vitamin B12 and folate supplementation in the prevention of osteoporotic fractures.

Trial Registration: The B-PROOF study is registered with the Netherlands Trial (NTR NTR1333) and with ClinicalTrials.gov (NCT00696514).

Citing Articles

Development of the ADFICE_IT clinical decision support system to assist deprescribing of fall-risk increasing drugs: A user-centered design approach.

Groos S, de Wildt K, de Loo B, Linn A, Medlock S, Shaw K PLoS One. 2024; 19(9):e0297703.

PMID: 39236057 PMC: 11376580. DOI: 10.1371/journal.pone.0297703.

The association between adherence to the EAT-Lancet diet and cognitive ageing.

van Soest A, van de Rest O, Witkamp R, de Groot L Age Ageing. 2024; 53(Suppl 2):ii39-ii46.

PMID: 38745489 PMC: 11094393. DOI: 10.1093/ageing/afae032.

The role of plasma concentrations and drug characteristics of beta-blockers in fall risk of older persons.

Ploegmakers K, van Poelgeest E, Seppala L, van Dijk S, de Groot L, Oliai Araghi S Pharmacol Res Perspect. 2023; 11(6):e01126.

PMID: 37885367 PMC: 10603288. DOI: 10.1002/prp2.1126.

The association between adherence to a plant-based diet and cognitive ageing.

van Soest A, van de Rest O, Witkamp R, Van der Velde N, de Groot L Eur J Nutr. 2023; 62(5):2053-2062.

PMID: 36905458 PMC: 10349692. DOI: 10.1007/s00394-023-03130-y.

Vitamin D, Folic Acid and Vitamin B Can Reverse Vitamin D Deficiency-Induced Learning and Memory Impairment by Altering 27-Hydroxycholesterol and S-Adenosylmethionine.

Wang L, Zhou C, Yu H, Hao L, Ju M, Feng W Nutrients. 2023; 15(1).

PMID: 36615790 PMC: 9824694. DOI: 10.3390/nu15010132.

References

. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002; 288(16):2015-22. DOI: 10.1001/jama.288.16.2015. View

Smith A . The worldwide challenge of the dementias: a role for B vitamins and homocysteine?. Food Nutr Bull. 2008; 29(2 Suppl):S143-72. DOI: 10.1177/15648265080292S119. View

Morris M, Jacques P, Selhub J . Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone. 2005; 37(2):234-42. DOI: 10.1016/j.bone.2005.04.017. View

Visser M, Fuerst T, Lang T, SALAMONE L, Harris T . Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study--Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985). 1999; 87(4):1513-20. DOI: 10.1152/jappl.1999.87.4.1513. View

Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B . Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005; 293(18):2257-64. DOI: 10.1001/jama.293.18.2257. View

Tucker K, Hannan M, Qiao N, Jacques P, Selhub J, Cupples L . Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res. 2004; 20(1):152-8. DOI: 10.1359/JBMR.041018. View

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A . Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone. 2003; 33(6):956-9. DOI: 10.1016/j.bone.2003.07.001. View

Kuzminski A, Del Giacco E, Allen R, Stabler S, Lindenbaum J . Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998; 92(4):1191-8. View

10.

Stone K, Bauer D, Sellmeyer D, Cummings S . Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab. 2004; 89(3):1217-21. DOI: 10.1210/jc.2003-030074. View

11.

Stel V, Smit J, Pluijm S, Visser M, Deeg D, Lips P . Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol. 2004; 57(3):252-8. DOI: 10.1016/j.jclinepi.2003.07.008. View

12.

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View

13.

Saito M, Fujii K, Marumo K . Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int. 2006; 79(3):160-8. DOI: 10.1007/s00223-006-0035-1. View

14.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

15.

Dhonukshe-Rutten R, Pluijm S, de Groot L, Lips P, Smit J, van Staveren W . Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res. 2005; 20(6):921-9. DOI: 10.1359/JBMR.050202. View

16.

Kim G, Kim C, Park J, Lee K, Park C . Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism. 1996; 45(12):1443-6. DOI: 10.1016/s0026-0495(96)90171-7. View

17.

. The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull. 1987; 34 Suppl 4:1-24. View

18.

Kanis J, Burlet N, Cooper C, Delmas P, Reginster J, Borgstrom F . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008; 19(4):399-428. PMC: 2613968. DOI: 10.1007/s00198-008-0560-z. View

19.

Kind P, Dolan P, Gudex C, Williams A . Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998; 316(7133):736-41. PMC: 28477. DOI: 10.1136/bmj.316.7133.736. View

20.

Kanis J, Johnell O . Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int. 2004; 16(3):229-38. DOI: 10.1007/s00198-004-1811-2. View